Compare Stocks: ILMN, QGEN, TMO, and ADPT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADPT Adaptive Biotechnologies	$28.37 +2.6%	$26.30	$12.00 ▼ $30.74	$4.53B	2.09	2.28 million shs	2.32 million shs
ILMN Illumina	$288.79 +3.3%	$247.14	$94.00 ▼ $309.35	$43.61B	1.41	2.16 million shs	2.24 million shs
QGEN Qiagen	$50.31 +0.3%	$44.89	$32.53 ▼ $57.81	$10.37B	0.61	2.78 million shs	4.53 million shs
TMO Thermo Fisher Scientific	$704.41 +1.6%	$651.61	$435.27 ▼ $710.84	$260.45B	0.87	2.27 million shs	1.65 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADPT Adaptive Biotechnologies	+2.57%	+12.00%	-0.49%	+17.33%	+67.87%
ILMN Illumina	+3.33%	+2.10%	+6.21%	+40.81%	+195.29%
QGEN Qiagen	+0.21%	+0.57%	+11.61%	+21.31%	-0.40%
TMO Thermo Fisher Scientific	+1.43%	+1.50%	+3.94%	+22.13%	+26.20%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADPT Adaptive Biotechnologies	$28.37 +2.6%	$26.30	$12.00 ▼ $30.74	$4.53B	2.09	2.28 million shs	2.32 million shs
ILMN Illumina	$288.79 +3.3%	$247.14	$94.00 ▼ $309.35	$43.61B	1.41	2.16 million shs	2.24 million shs
QGEN Qiagen	$50.31 +0.3%	$44.89	$32.53 ▼ $57.81	$10.37B	0.61	2.78 million shs	4.53 million shs
TMO Thermo Fisher Scientific	$704.41 +1.6%	$651.61	$435.27 ▼ $710.84	$260.45B	0.87	2.27 million shs	1.65 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADPT Adaptive Biotechnologies	+2.57%	+12.00%	-0.49%	+17.33%	+67.87%
ILMN Illumina	+3.33%	+2.10%	+6.21%	+40.81%	+195.29%
QGEN Qiagen	+0.21%	+0.57%	+11.61%	+21.31%	-0.40%
TMO Thermo Fisher Scientific	+1.43%	+1.50%	+3.94%	+22.13%	+26.20%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADPT Adaptive Biotechnologies	2.63	Moderate Buy	$30.06	5.97% Upside
ILMN Illumina	2.42	Hold	$234.41	-18.83% Downside
QGEN Qiagen	2.27	Hold	$46.09	-8.38% Downside
TMO Thermo Fisher Scientific	2.83	Moderate Buy	$684.55	-2.82% Downside

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and ADPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/28/2026	QGEN Qiagen	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Overweight ➝ Equal Weight	$55.00 ➝ $53.00
10/26/2026	QGEN Qiagen	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral	$45.00 ➝ $52.00
10/26/2026	QGEN Qiagen	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral ➝ Hold	$45.00 ➝ $52.00
10/23/2026	ILMN Illumina	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight ➝ Equal Weight	$275.00
10/23/2026	TMO Thermo Fisher Scientific	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$685.00 ➝ $800.00
10/23/2026	ILMN Illumina	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Overweight ➝ Equal Weight	$275.00
10/23/2026	TMO Thermo Fisher Scientific	DZ Bank Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
10/22/2026	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$800.00
10/22/2026	TMO Thermo Fisher Scientific	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Sector Perform	$580.00 ➝ $730.00
10/22/2026	TMO Thermo Fisher Scientific	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$750.00 ➝ $775.00
10/22/2026	QGEN Qiagen	DZ Bank Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold

(Data available from 10/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADPT Adaptive Biotechnologies	$276.98M	16.35	N/A	N/A	$1.47 per share	19.30
ILMN Illumina	$4.34B	10.04	$7.20 per share	40.12	$17.82 per share	16.21
QGEN Qiagen	$2.09B	4.96	$3.40 per share	14.80	$17.89 per share	2.81
TMO Thermo Fisher Scientific	$47.35B	5.50	$31.79 per share	22.16	$142.17 per share	4.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADPT Adaptive Biotechnologies	-$59.50M	-$0.41	N/A	N/A	N/A	-20.73%	-36.81%	-13.77%	11/4/2026 (Estimated)
ILMN Illumina	$850M	$5.36	53.88	47.19	3.82	18.36%	29.84%	12.17%	10/29/2026 (Estimated)
QGEN Qiagen	$424.88M	$1.95	25.78	19.27	5.01	19.49%	14.47%	8.34%	11/4/2026 (Estimated)
TMO Thermo Fisher Scientific	$6.70B	$18.96	37.15	25.37	2.75	14.94%	17.33%	8.18%	N/A

Latest ILMN, QGEN, TMO, and ADPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	ADPT Adaptive Biotechnologies	-$0.0911	N/A	N/A	N/A	$71.57 million	N/A
11/4/2026	Q3 2026	QGEN Qiagen	$0.6270	N/A	N/A	N/A	$538.61 million	N/A
10/29/2026	Q3 2026	ILMN Illumina	$1.36	N/A	N/A	N/A	$1.15 billion	N/A
10/21/2026	Q3 2026	TMO Thermo Fisher Scientific	$6.40	$6.68	+$0.28	$4.64	$11.95 billion	$12.14 billion
8/5/2026	Q2 2026	QGEN Qiagen	$0.5980	$0.62	+$0.0220	$0.50	$527.50 million	$535.04 million
7/30/2026	Q2 2026	ILMN Illumina	$1.23	$1.31	+$0.08	$1.35	$1.13 billion	$1.16 billion
7/29/2026	Q2 2026	ADPT Adaptive Biotechnologies	-$0.1336	-$0.25	-$0.1164	-$0.25	$65.44 million	$71.55 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADPT Adaptive Biotechnologies	N/A	N/A	N/A	N/A	N/A
ILMN Illumina	N/A	N/A	N/A	N/A	N/A
QGEN Qiagen	$0.35	0.70%	N/A	17.95%	N/A
TMO Thermo Fisher Scientific	$1.88	0.27%	+14.34%	9.92%	8 Years

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADPT Adaptive Biotechnologies	2.22	4.79	4.68
ILMN Illumina	0.53	1.80	1.40
QGEN Qiagen	0.48	2.85	2.31
TMO Thermo Fisher Scientific	0.71	1.81	1.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADPT Adaptive Biotechnologies	99.17%
ILMN Illumina	89.42%
QGEN Qiagen	70.00%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
ADPT Adaptive Biotechnologies	5.70%
ILMN Illumina	2.90%
QGEN Qiagen	9.00%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADPT Adaptive Biotechnologies	624	159.60 million	150.50 million	Optionable
ILMN Illumina	8,650	151.00 million	146.62 million	Optionable
QGEN Qiagen	5,654	206.07 million	187.53 million	Optionable
TMO Thermo Fisher Scientific	125,000	369.75 million	368.53 million	Optionable

ILMN, QGEN, TMO, and ADPT Headlines

Recent News About These Companies

2,793 Thermo Fisher Scientific Inc. $TMO Shares Sold by MORGUARD LINCLUDEN GLOBAL INVESTMENTS Ltd

2 hours ago | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Shares Sold by Conning Inc.

4 hours ago | marketbeat.com

Thermo Fisher (TMO) Stock Could Trade At A Premium On Strong Q3 Results

4 hours ago | finance.yahoo.com

Is Thermo Fisher Scientific (TMO) Fully Priced On Its Latest Results?

4 hours ago | finance.yahoo.com

Thermo Fisher Scientific Inc. $TMO Stock Sold by Convergence Financial LLC

October 29 at 4:07 AM | marketbeat.com

2,574 Thermo Fisher Scientific Inc. $TMO Shares Sold by Ashton Thomas Securities LLC

October 29 at 3:27 AM | marketbeat.com

Thermo Fisher Scientific Reaches $704 and a New 52-Week High

October 28 at 11:15 PM | 247wallst.com

Custom Recombinant Protein Production Services Market Projected to Reach $10.21 Billion by 2030 | Thermo Fisher, Merck, GenScript, and Sino Biological Dominate

October 28 at 1:14 PM | finance.yahoo.com

Microarray Scanners - Global Strategic Business Report 2026: Capitalize on $1.6 Billion Industry Revenue by 2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina, and Bio-Rad Laboratories Dominate

October 28 at 1:14 PM | finance.yahoo.com

Thermo Fisher Scientific (NYSE:TMO) Sets New 12-Month High - Here's What Happened

October 28 at 12:39 PM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Stock Position Boosted by WestEnd Advisors LLC

October 28 at 6:23 AM | marketbeat.com

Verdence Capital Advisors LLC Buys New Holdings in Thermo Fisher Scientific Inc. $TMO

October 27 at 6:08 AM | marketbeat.com

Cell and Gene Therapy Contract Research Organization Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, IQVIA, Labcorp, ICON, and WuXi AppTec Scale Integrated Trials

October 26 at 4:07 PM | finance.yahoo.com

3 healthcare stocks we keep off our radar

October 26 at 4:07 PM | finance.yahoo.com

Thermo Fisher Scientific (NYSE:TMO) Cut to Hold at DZ Bank

October 26 at 1:54 AM | americanbankingnews.com

Thermo Fisher Scientific (NYSE:TMO) Rating Lowered to Hold at DZ Bank

October 24, 2026 | marketbeat.com

Thermo Fisher Scientific (NYSE:TMO) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

October 24, 2026 | americanbankingnews.com

Thermo Fisher Scientific (NYSE:TMO) Stock Price Expected to Rise, Robert W. Baird Analyst Says

October 24, 2026 | americanbankingnews.com

TD Cowen Forecasts Strong Price Appreciation for Thermo Fisher Scientific (NYSE:TMO) Stock

October 24, 2026 | americanbankingnews.com

Thermo Fisher Scientific (TMO) Benefits on Broad-Based Recovery Across Life-Science Markets

October 23, 2026 | finance.yahoo.com

Should Illumina Stock Holders Look At Thermo Fisher Instead?

October 23, 2026 | trefis.comT

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and ADPT Company Descriptions

Adaptive Biotechnologies NASDAQ:ADPT

$28.37 +0.71 (+2.57%)

Closing price 10/28/2026 04:00 PM Eastern

Extended Trading

$28.24 -0.14 (-0.48%)

As of 09:09 AM Eastern

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Illumina NASDAQ:ILMN

$288.79 +9.32 (+3.33%)

Closing price 10/28/2026 04:00 PM Eastern

Extended Trading

$289.58 +0.78 (+0.27%)

As of 09:11 AM Eastern

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Qiagen NYSE:QGEN

$50.31 +0.14 (+0.27%)

Closing price 10/28/2026 03:59 PM Eastern

Extended Trading

$50.20 -0.11 (-0.21%)

As of 09:02 AM Eastern

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Thermo Fisher Scientific NYSE:TMO

$704.41 +11.39 (+1.64%)

Closing price 10/28/2026 03:59 PM Eastern

Extended Trading

$711.24 +6.83 (+0.97%)

As of 09:12 AM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and ADPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ILMN, QGEN, TMO, and ADPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ILMN, QGEN, TMO, and ADPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and ADPT Company Descriptions

Adaptive Biotechnologies NASDAQ:ADPT

Illumina NASDAQ:ILMN

Qiagen NYSE:QGEN

Thermo Fisher Scientific NYSE:TMO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and ADPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ILMN, QGEN, TMO, and ADPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ILMN, QGEN, TMO, and ADPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and ADPT Company Descriptions

Adaptive Biotechnologies NASDAQ:ADPT

Illumina NASDAQ:ILMN

Qiagen NYSE:QGEN

Thermo Fisher Scientific NYSE:TMO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools